In this Deep Dive Session, Prof. Mohamad Mohty discusses the latest advancements in the treatment of multiple myeloma, including the use of novel therapies and the importance of genetic testing in guiding treatment decisions. He emphasizes the need for personalized treatment plans and the potential of immunotherapies, such as bispecific antibodies and CAR-T cells..